V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280002959 | 280002237 | 1.72 | 80.7 | Curative (C) | 2014-09-05 | 2014-09-18 | CETUXIMAB + RT | N | N | 280024722 | CETUXIMAB + RT |
| 280002960 | 280002237 | 1.8 | 73 | Curative (C) | 2016-07-23 | 2016-07-24 | Cetuximab + Radiotherapy Load | 2 | N | 280024722 | CETUXIMAB + RT |
| 280002961 | 280009694 | 1.5 | 107.4 | Curative (C) | 2013-09-27 | 2013-09-29 | CETUXIMAB + RT | 02 | null | 280024728 | CETUXIMAB + RT |
| 280002962 | 280002238 | 1.85 | null | Palliative (P) | 2017-01-05 | 2017-01-17 | CISPLATIN + FLUOROURACIL | 02 | N | 280024732 | CISPLATIN + FLUOROURACIL |
| 280002963 | 280002239 | null | 77 | Neo-adjuvant (N) | 2018-05-30 | 2018-05-30 | DOXORUBICIN + IFOSFAMIDE | 2 | null | 280024733 | DOXORUBICIN + IFOSFAMIDE |
| 280002964 | 280002240 | 1.8 | 79.8 | Palliative (P) | 2016-05-25 | 2016-05-25 | Doxorubicin + Ifosfamide | 02 | N | 280024734 | DOXORUBICIN + IFOSFAMIDE |
| 280002965 | 280002241 | 1.6 | 74 | Curative (C) | null | 2014-05-10 | CISPLATIN + FLUOROURACIL | N | N | 280024736 | CISPLATIN + FLUOROURACIL |
| 280002966 | 280002242 | 1.82 | 110.4 | Neo-adjuvant (N) | null | 2013-04-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024737 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002967 | 280002243 | 1.81 | 60.5 | Neo-adjuvant (N) | 2014-02-13 | 2014-02-14 | Cisplatin +Fluorouracil (3 wk) | 02 | null | 280024738 | CISPLATIN + FLUOROURACIL |
| 280002968 | 280002244 | 1.8 | 91.8 | Neo-adjuvant (N) | 2015-05-10 | 2015-05-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024740 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002969 | 280002245 | 1.71 | 66.4 | Curative (C) | 2016-08-22 | 2016-08-23 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024741 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002970 | 280002246 | 1.58 | 109.6 | Neo-adjuvant (N) | 2015-10-29 | 2015-10-29 | CISPLATIN + FLUOROURACIL | 2 | null | 280024744 | CISPLATIN + FLUOROURACIL |
| 280002971 | 280002246 | 1.7 | 96.8 | Neo-adjuvant (N) | 2014-09-27 | 2014-10-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024744 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002972 | 280002247 | 1.8 | 126.5 | Palliative (P) | 2013-02-01 | 2013-02-02 | Doxorubicin + Ifosfamide | 02 | N | 280024748 | DOXORUBICIN + IFOSFAMIDE |
| 280002973 | 280002248 | 1.76 | 0.1 | null | 2016-11-11 | 2016-11-30 | Doxorubicin + Ifosfamide | N | N | 280024750 | DOXORUBICIN + IFOSFAMIDE |
| 280002974 | 280002249 | 1.87 | 62 | Curative (C) | 2015-08-20 | 2015-08-25 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024753 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002975 | 280002250 | null | 58 | Adjuvant (A) | 2017-02-06 | 2017-02-06 | Doxorubicin + Ifosfamide | N | N | 280024755 | DOXORUBICIN + IFOSFAMIDE |
| 280002976 | 280002251 | 1.8 | 87.7 | Neo-adjuvant (N) | 2017-08-03 | 2017-08-11 | CISPLATIN + FLUOROURACIL | 02 | null | 280024756 | CISPLATIN + FLUOROURACIL |
| 280002977 | 280007214 | null | null | Neo-adjuvant (N) | null | 2014-07-01 | CETUXIMAB + RT | null | Y | 280024757 | CETUXIMAB + RT |
| 280002978 | 280002252 | 1.65 | 74.2 | Curative (C) | 2016-06-23 | 2016-06-27 | Doxorubicin + Ifosfamide | 02 | N | 280024759 | DOXORUBICIN + IFOSFAMIDE |
| 280002979 | 280002253 | 1.76 | 80 | Neo-adjuvant (N) | 2013-08-31 | 2013-08-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280024762 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002980 | 280002254 | 1.61 | null | Neo-adjuvant (N) | 2014-12-26 | 2014-12-27 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024764 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002981 | 280002255 | 1.67 | 60.5 | null | 2013-06-04 | 2013-06-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024767 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002982 | 280002256 | 1.83 | 83 | Neo-adjuvant (N) | 2015-11-15 | 2015-11-20 | DOXORUBICIN + IFOSFAMIDE | N | N | 280024768 | DOXORUBICIN + IFOSFAMIDE |
| 280002983 | 280002256 | 1.75 | 81 | null | 2015-08-03 | 2015-08-03 | Doxorubicin + Ifosfamide | 02 | N | 280024768 | DOXORUBICIN + IFOSFAMIDE |
| 280002984 | 280002256 | 1.77 | 0 | Adjuvant (A) | 2015-04-24 | 2015-08-22 | Cetuximab + Radiotherapy Load | N | Y | 280024768 | CETUXIMAB + RT |
| 280002985 | 280002257 | 1.76 | 107 | Neo-adjuvant (N) | 2016-02-05 | 2016-02-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280024772 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002986 | 280002258 | 1.63 | 68.2 | null | 2016-02-16 | 2016-02-17 | Doxorubicin + Ifosfamide | N | N | 280024774 | DOXORUBICIN + IFOSFAMIDE |
| 280002987 | 280002258 | 1.67 | 104.3 | Curative (C) | 2014-04-03 | 2014-04-10 | CETUXIMAB + RT | 02 | null | 280024774 | CETUXIMAB + RT |
| 280002988 | 280002258 | 1.81 | 109 | Curative (C) | 2015-03-09 | 2015-03-29 | Cetuximab + Radiotherapy Load | 02 | N | 280024774 | CETUXIMAB + RT |
| 280002989 | 280002259 | 1.67 | 106.4 | Not known (9) | null | 2016-05-04 | CISPLATIN + FLUOROURACIL | N | Y | 280024777 | CISPLATIN + FLUOROURACIL |
| 280002990 | 280002260 | 1.57 | null | Neo-adjuvant (N) | 2015-08-28 | 2015-09-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280024778 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002991 | 280002261 | null | null | Palliative (P) | 2013-05-18 | 2013-05-18 | Doxorubicin + Ifosfamide | N | N | 280024779 | DOXORUBICIN + IFOSFAMIDE |
| 280002992 | 280002262 | 1.87 | 92 | Curative (C) | 2017-07-29 | 2017-07-30 | Cetuximab + Radiotherapy Load | N | Y | 280024781 | CETUXIMAB + RT |
| 280002993 | 280007217 | 1.72 | 63.75 | Neo-adjuvant (N) | null | 2016-08-08 | Doxorubicin + Ifosfamide | N | N | 280024782 | DOXORUBICIN + IFOSFAMIDE |
| 280002994 | 280002263 | 1.71 | 82.2 | Curative (C) | 2014-02-02 | 2014-02-24 | Cetuximab + Radiotherapy Load | N | Y | 280024783 | CETUXIMAB + RT |
| 280002995 | 280002264 | 1.69 | 92.4 | Neo-adjuvant (N) | 2016-01-20 | 2016-01-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | null | 280024787 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002996 | 280002265 | 1.62 | 57.2 | Neo-adjuvant (N) | 2017-08-03 | 2017-08-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024790 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002997 | 280002266 | 1.78 | 82.8 | Neo-adjuvant (N) | 2017-11-29 | 2017-11-29 | Doxorubicin + Ifosfamide | 02 | N | 280024792 | DOXORUBICIN + IFOSFAMIDE |
| 280002998 | 280002267 | null | null | Curative (C) | null | 2016-09-22 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024793 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280002999 | 280002268 | 1.58 | 64 | Curative (C) | 2013-11-05 | 2013-11-05 | CETUXIMAB + RT | N | Y | 280024795 | CETUXIMAB + RT |
| 280003000 | 280002269 | 1.75 | 70.6 | Palliative (P) | null | 2015-07-21 | CISPLATIN + FLUOROURACIL | null | null | 280024797 | CISPLATIN + FLUOROURACIL |
| 280003001 | 280007218 | 1.58 | 90.7 | Neo-adjuvant (N) | 2017-05-18 | 2017-05-25 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024798 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003002 | 280007218 | 1.77 | 73 | Neo-adjuvant (N) | 2015-03-17 | 2015-04-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024798 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003003 | 280002270 | 1.88 | 57.4 | Palliative (P) | 2014-10-15 | 2014-11-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024802 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003004 | 280002270 | 1.75 | 87.4 | Neo-adjuvant (N) | null | 2014-01-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280024802 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003005 | 280002271 | null | 78.2 | Neo-adjuvant (N) | 2017-02-08 | 2017-04-04 | Cisplatin + Docetaxel +Fluorouracil | N | null | 280024804 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003006 | 280002272 | 1.81 | 81.4 | Neo-adjuvant (N) | 2014-04-12 | 2014-04-16 | Cisplatin + Docetaxel +Fluorouracil | 99 | N | 280024810 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003007 | 280002273 | 1.67 | 79.7 | Neo-adjuvant (N) | 2015-02-07 | 2015-02-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280024811 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280003008 | 280002274 | 1.7 | 74.9 | Adjuvant (A) | 2013-03-03 | 2013-03-09 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 280024812 | DOXORUBICIN + IFOSFAMIDE |